We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors

By MedImaging International staff writers
Posted on 05 Jan 2024
Print article
Image: A research team has drawn up criteria for PET-based examinations of malignant brain tumors (Photo courtesy of 123RF)
Image: A research team has drawn up criteria for PET-based examinations of malignant brain tumors (Photo courtesy of 123RF)

Diffuse gliomas, which are aggressive malignant brain tumors originating from glial cells, present significant treatment challenges. Standard magnetic resonance imaging (MRI) techniques do not adequately capture the complexity of diffuse gliomas. Instead, amino acid positron emission tomography (PET) has become a crucial tool in diagnosing these tumors. This method utilizes protein-based tracers (amino acids) that accumulate in brain tumors, offering more accurate insights into the activity and extent of gliomas. Despite its extensive use in neuro-oncology for years, amino acid PET had not undergone systematic evaluation, and unlike MRI diagnostics, there have been no established criteria for interpreting these PET images.

Now, the international Response Assessment in Neuro-Oncology (RANO) Working Group, guided by experts from Ludwig Maximilian University of Munich (LMU, Munich, Germany) and the Medical University of Vienna (Vienna, Austria), has introduced the first-ever global standards for gliomas imaging using amino acid PET. The RANO Working Group, a diverse international consortium with a decade-long history of developing criteria to serve as standard references for brain tumor-related clinical studies, has made significant strides in assessing various critical clinical aspects.

The RANO group has formulated PET RANO 1.0, a set of criteria aimed at evaluating the effectiveness of treatments for diffuse gliomas using PET. These PET-based standards usher in novel avenues for the uniform assessment of diffuse gliomas. The researchers believe that these new criteria not only facilitate the use of PET in clinical trials and routine practice but also lay a solid groundwork for future investigations, fostering the comparison and enhancement of treatment modalities for better therapeutic outcomes.

Related Links:
LMU
Medical University of Vienna

Gold Member
Ultrasound System
FUTUS LE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Double Sided Apron
Maxima
Forensic Imaging System
EXERO-DR

Print article
Radcal

Channels

MRI

view channel
Image: PET/MRI can accurately classify prostate cancer patients (Photo courtesy of 123RF)

PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients

The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more